Alaunos Therapeutics, Inc. Increase (Decrease) in Other Deferred Liability
Alaunos Therapeutics, Inc. (TCRT) reported Increase (Decrease) in Other Deferred Liability of $19.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2015-08-10
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for the quarter ending 2015-06-30 was -$89.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for the quarter ending 2015-03-31 was $108.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for the quarter ending 2014-12-31 was -$59.00K, a 109.56% decline year-over-year.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for the quarter ending 2014-09-30 was -$56.00K, a 394.74% decline year-over-year.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for fiscal 2014 was -$213.00K, a 134.08% decline from fiscal 2013.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for fiscal 2013 was $625.00K, a 156.15% increase from fiscal 2012.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for fiscal 2012 was $244.00K, a 123.85% increase from fiscal 2011.
- Alaunos Therapeutics, Inc. increase (decrease) in other deferred liability for fiscal 2011 was $109.00K.
| Period end | Increase (Decrease) in Other Deferred Liability 3 month | Increase (Decrease) in Other Deferred Liability 6 month | Increase (Decrease) in Other Deferred Liability 9 month | Increase (Decrease) in Other Deferred Liability 12 month | Increase (Decrease) in Other Deferred Liability 85 month | Increase (Decrease) in Other Deferred Liability 94 month | Increase (Decrease) in Other Deferred Liability 97 month | Increase (Decrease) in Other Deferred Liability 100 month | Increase (Decrease) in Other Deferred Liability 103 month | Increase (Decrease) in Other Deferred Liability 106 month | Increase (Decrease) in Other Deferred Liability 109 month | Increase (Decrease) in Other Deferred Liability 112 month | Increase (Decrease) in Other Deferred Liability 115 month | Increase (Decrease) in Other Deferred Liability 118 month | Increase (Decrease) in Other Deferred Liability 121 month | Increase (Decrease) in Other Deferred Liability 124 month | Increase (Decrease) in Other Deferred Liability 127 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $19.00K 10-Q · filed 2015-08-10 | -$40.00K derived: sum of 3 quarters · filed 2015-08-10 | -$96.00K derived: sum of 4 quarters · filed 2015-08-10 | |||||||||||||
| 2015-03-31 | $108.00K 10-Q · filed 2015-05-07 | $49.00K derived: sum of 2 quarters · filed 2015-05-07 | -$7.00K derived: sum of 3 quarters · filed 2015-05-07 | -$58.00K derived: sum of 4 quarters · filed 2015-08-10 | |||||||||||||
| 2014-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$115.00K derived: sum of 2 quarters · filed 2015-02-26 | -$166.00K derived: sum of 3 quarters · filed 2015-08-10 | -$213.00K 10-K · filed 2015-02-26 | |||||||||||||
| 2014-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$107.00K derived: sum of 2 quarters · filed 2015-08-10 | -$154.00K 10-Q · filed 2014-10-30 | $463.00K derived: sum of 4 quarters · filed 2015-08-10 | |||||||||||||
| 2014-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$98.00K 10-Q · filed 2015-08-10 | $519.00K derived: sum of 3 quarters · filed 2015-08-10 | $538.00K derived: sum of 4 quarters · filed 2015-08-10 | |||||||||||||
| 2014-03-31 | -$47.00K 10-Q · filed 2015-05-07 | $570.00K derived: sum of 2 quarters · filed 2015-05-07 | $589.00K derived: sum of 3 quarters · filed 2015-05-07 | $575.00K derived: sum of 4 quarters · filed 2015-05-07 | $1.02M 10-Q · filed 2014-05-08 | ||||||||||||
| 2013-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $636.00K derived: sum of 2 quarters · filed 2015-02-26 | $622.00K derived: sum of 3 quarters · filed 2015-02-26 | $625.00K 10-K · filed 2015-02-26 | $1.06M 10-K · filed 2014-03-03 | ||||||||||||
| 2013-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $5.00K derived: sum of 2 quarters · filed 2014-10-30 | $8.00K 10-Q · filed 2014-10-30 | $26.00K derived: sum of 4 quarters · filed 2015-02-26 | $447.00K 10-Q · filed 2013-10-22 | ||||||||||||
| 2013-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$11.00K 10-Q · filed 2014-08-07 | $7.00K derived: sum of 3 quarters · filed 2015-02-26 | $61.00K derived: sum of 4 quarters · filed 2015-02-26 | $428.00K 10-Q · filed 2013-08-08 | ||||||||||||
| 2013-03-31 | $3.00K 10-Q · filed 2014-05-08 | $21.00K derived: sum of 2 quarters · filed 2015-02-26 | $75.00K derived: sum of 3 quarters · filed 2015-02-26 | $114.00K derived: sum of 4 quarters · filed 2015-02-26 | $442.00K 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $72.00K derived: sum of 2 quarters · filed 2015-02-26 | $111.00K derived: sum of 3 quarters · filed 2015-02-26 | $244.00K 10-K · filed 2015-02-26 | $439.00K 10-K · filed 2013-03-18 | ||||||||||||
| 2012-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $93.00K derived: sum of 2 quarters · filed 2013-10-22 | $226.00K 10-Q · filed 2013-10-22 | $323.00K derived: sum of 4 quarters · filed 2014-03-03 | $421.00K 10-Q · filed 2012-11-08 | ||||||||||||
| 2012-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $172.00K 10-Q · filed 2013-08-08 | $269.00K derived: sum of 3 quarters · filed 2014-03-03 | $286.00K derived: sum of 4 quarters · filed 2014-03-03 | $367.00K 10-Q/A · filed 2012-08-28 | ||||||||||||
| 2012-03-31 | $133.00K 10-Q · filed 2013-05-07 | $230.00K derived: sum of 2 quarters · filed 2014-03-03 | $247.00K derived: sum of 3 quarters · filed 2014-03-03 | $249.00K derived: sum of 4 quarters · filed 2014-03-03 | $328.00K 10-Q · filed 2012-05-03 | ||||||||||||
| 2011-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $114.00K derived: sum of 2 quarters · filed 2014-03-03 | $116.00K derived: sum of 3 quarters · filed 2014-03-03 | $109.00K 10-K · filed 2014-03-03 | $195.00K 10-K · filed 2012-02-29 | ||||||||||||
| 2011-09-30 | $17.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08 | $19.00K derived: sum of 2 quarters · filed 2012-11-08 | $12.00K 10-Q · filed 2012-11-08 | $3.00K derived: sum of 4 quarters · filed 2013-03-18 | $98.00K 10-Q · filed 2011-11-03 | ||||||||||||
| 2011-06-30 | $2.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28 | -$5.00K 10-Q/A · filed 2012-08-28 | -$14.00K derived: sum of 3 quarters · filed 2013-03-18 | -$1.00K derived: sum of 4 quarters · filed 2013-03-18 | $81.00K 10-Q/A · filed 2011-08-09 | ||||||||||||
| 2011-03-31 | -$7.00K 10-Q · filed 2012-05-03 | -$16.00K derived: sum of 2 quarters · filed 2013-03-18 | -$3.00K derived: sum of 3 quarters · filed 2013-03-18 | ||||||||||||||
| 2010-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $4.00K derived: sum of 2 quarters · filed 2013-03-18 | -$24.00K 10-K · filed 2013-03-18 | ||||||||||||||
| 2010-09-30 | $13.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-03 | -$15.00K 10-Q · filed 2011-11-03 | $95.00K 10-Q · filed 2011-08-01 | ||||||||||||||
| 2010-06-30 | -$28.00K 10-Q/A · filed 2011-08-09 | ||||||||||||||||
| 2009-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$32.00K 10-K · filed 2012-02-29 | |||||||||||||||
| 2009-09-30 | -$22.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |